We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$832M
1-Year Est. Return
32.38%
This Fund
S&P 500
This Quarter
Est. Return
-6.55%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$4.6B
AUM Growth
-$358M
(-7.2%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
84.57%
Holding
69
New
20
Increased
2
Reduced
18
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$220M |
| 2 |
Advanced Micro Devices
AMD
|
+$159M |
| 3 |
ArriVent BioPharma
AVBP
|
+$79.3M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
+$61.2M |
| 5 |
TSMC
TSM
|
+$12.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$82.3M |
| 2 |
Alibaba
BABA
|
+$78.9M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
+$66M |
| 4 |
DoorDash
DASH
|
+$52.9M |
| 5 |
Baidu
BIDU
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 36.91% |
| 2 | Healthcare | 33.02% |
| 3 | Technology | 15.02% |
| 4 | Real Estate | 8.7% |
| 5 | Communication Services | 3.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aligos Therapeutics
ALGS
$44.1M
| $1.87M | 0.04% |
76,248
| – | – |
|
52
JD.com
JD
$38.5B
| $1.68M | 0.04% |
61,250
-1,389,900
| -96% | -$34M |
|
53
Pyxis Oncology
PYXS
$277M
| $1.63M | 0.04% |
382,606
| – | – |
|
|
MOGU
54
MOGU Inc
MOGU
$15.3M
| $1.6M | 0.03% |
847,510
| – | – |
|
55
Kanzhun
BZ
$8.04B
| $1.56M | 0.03% |
89,100
-34,600
| -28% | -$546K |
|
56
Arista Networks
ANET
$254B
| $1.04M | 0.02% |
+14,400
| New | +$971K |
|
57
Atour Lifestyle Holdings
ATAT
$4.72B
| $897K | 0.02% |
50,000
-150,000
| -75% | -$2.75M |
|
|
LSB
58
DELISTED
LakeShore Biopharma
LSB
| $526K | 0.01% |
75,179
| – | – |
|
59
Qualcomm
QCOM
$176B
| $508K | 0.01% |
+3,000
| New | +$464K |
|
60
Full Truck Alliance
YMM
$9.1B
| $98.3K | ﹤0.01% |
13,519
-2,239,023
| -99% | -$14.9M |
|
|
RDGT
61
Ridgetech Inc
RDGT
$3.5M
| $62.9K | ﹤0.01% |
134
| – | – |
|
62
Constellation Energy
CEG
$100B
| $55.5K | ﹤0.01% |
+300
| New | +$42.6K |
|
|
UXIN
63
Uxin Ltd
UXIN
$257M
| $40.6K | ﹤0.01% |
19,156
| – | – |
|
64
Datadog
DDOG
$87.2B
| – | – |
-85,100
| Closed | -$10.3M |
|
65
Futu Holdings
FUTU
$17.5B
| – | – |
-80,000
| Closed | -$4.37M |
|
66
iQIYI
IQ
$892M
| – | – |
-142,500
| Closed | -$695K |
|
67
Neumora Therapeutics
NMRA
$278M
| – | – |
-1,699,313
| Closed | -$29M |
|
68
Playtika
PLTK
$877M
| – | – |
-72,800
| Closed | -$635K |
|
|
RYZB
69
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| – | – |
-1,062,383
| Closed | -$66M |
|
Similar funds
ACGDR
NCM
SIG
AFA
BEC
AFA
BCG
AWA
HHLR Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, HHLR Advisors held 69 positions worth $4.6B, down 7.2% from $4.96B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
HHLR Advisors's Q1 2024 filing shows 20 new, 2 increased, 18 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 912,400 shares worth $165M. The largest sale was Salesforce, an estimated $82.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.
- HHLR Advisors's largest Q1 2024 buy was Advanced Micro Devices: 912,400 shares worth $165M.
- HHLR Advisors added most to Pinduoduo in Q1 2024, an estimated $220M increase.
- HHLR Advisors's biggest Q1 2024 reduction was Salesforce, cutting an estimated $82.3M.
- HHLR Advisors fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $66M.
- HHLR Advisors's ten largest holdings make up 85% of its $4.6B portfolio in Q1 2024.
- HHLR Advisors opened 20 new positions and closed 6 in Q1 2024.
- HHLR Advisors's portfolio value fell 7.2% quarter-over-quarter to $4.6B.
Based on HHLR Advisors's 13F filing for Q1 2024, filed 14 May 2024.